Picotech empowers the medical imaging industry with a cutting-edge, organ-specific PET scanner that detects small, aggressive tumours early when they are still curable.
EXEQ structured and executed Picotech’s funding plan, creating a public funding strategy roadmap, successful proposals (EUREKA Eurostars and Innowide schemes), and a feasibility study with interviews from early adopters in Poland. The partnership continues, with EXEQ joining one of Picotech’s investment rounds.
Scope:
- Funding Roadmap
- Grant Writing
- Customer Development
- Feasibility Study
Transforming Medical Innovation into Market Impact
Facing the challenge of securing substantial capital for Picotech’s innovative medical device, selecting the right funding schemes and R&D partners was crucial for future success.
Our priorities focused on:
- Accelerating the device’s time to market
- Identifying funding programs and R&D partners
- Preparing Picotech for commercialisation by addressing market regulations, exploring new markets (US), and gathering customer feedback.
We worked alongside Picotech's growth hack team
Driving the process with the Picotech founders, EXEQ successfully secured R&D funding while shaping the commercialisation plan.
We set priorities on:
- Securing R&D funding through the Eurostars program
- Supporting the investment round
- Conducting a Feasibility study and interviews with early adopters
- Initiating pilot programs with medical establishments to mitigate financial risk
- Preparing for entering the US market with Innowwide funding
